CN113080447A - 一种适用于高脂血症康复、散结化瘀、气血双调的食疗产品 - Google Patents
一种适用于高脂血症康复、散结化瘀、气血双调的食疗产品 Download PDFInfo
- Publication number
- CN113080447A CN113080447A CN202110384415.3A CN202110384415A CN113080447A CN 113080447 A CN113080447 A CN 113080447A CN 202110384415 A CN202110384415 A CN 202110384415A CN 113080447 A CN113080447 A CN 113080447A
- Authority
- CN
- China
- Prior art keywords
- parts
- blood
- hyperlipidemia
- stasis
- ginseng
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000004369 blood Anatomy 0.000 title claims abstract description 37
- 239000008280 blood Substances 0.000 title claims abstract description 37
- 208000031226 Hyperlipidaemia Diseases 0.000 title claims abstract description 16
- 235000013305 food Nutrition 0.000 title claims abstract description 16
- 238000002560 therapeutic procedure Methods 0.000 title claims abstract description 12
- 230000033228 biological regulation Effects 0.000 title claims abstract description 10
- 230000008030 elimination Effects 0.000 title claims description 3
- 238000003379 elimination reaction Methods 0.000 title claims description 3
- 241000208340 Araliaceae Species 0.000 claims abstract description 22
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 22
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 22
- 235000008434 ginseng Nutrition 0.000 claims abstract description 22
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 21
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 21
- 235000003145 Hippophae rhamnoides Nutrition 0.000 claims abstract description 18
- 244000223760 Cinnamomum zeylanicum Species 0.000 claims abstract description 17
- 235000017803 cinnamon Nutrition 0.000 claims abstract description 17
- 239000000843 powder Substances 0.000 claims abstract description 17
- 241000361919 Metaphire sieboldi Species 0.000 claims abstract description 16
- 240000007126 Citrus medica var. sarcodactylis Species 0.000 claims abstract description 15
- 241001264174 Cordyceps militaris Species 0.000 claims abstract description 15
- 235000013557 nattō Nutrition 0.000 claims abstract description 15
- 108010010803 Gelatin Proteins 0.000 claims abstract description 13
- 229920000159 gelatin Polymers 0.000 claims abstract description 13
- 239000008273 gelatin Substances 0.000 claims abstract description 13
- 235000019322 gelatine Nutrition 0.000 claims abstract description 13
- 235000011852 gelatine desserts Nutrition 0.000 claims abstract description 13
- 229940026314 red yeast rice Drugs 0.000 claims abstract description 13
- 241000133134 Saussurea Species 0.000 claims abstract description 12
- 244000077995 Coix lacryma jobi Species 0.000 claims abstract description 8
- 240000000950 Hippophae rhamnoides Species 0.000 claims abstract 5
- 235000005911 diet Nutrition 0.000 claims description 10
- 238000003860 storage Methods 0.000 claims description 10
- 241000271042 Gloydius halys Species 0.000 claims description 5
- 230000037213 diet Effects 0.000 claims description 4
- 238000009835 boiling Methods 0.000 claims description 2
- 230000000378 dietary effect Effects 0.000 claims 6
- 240000002853 Nelumbo nucifera Species 0.000 claims 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 20
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract description 12
- 230000001737 promoting effect Effects 0.000 abstract description 11
- 239000003814 drug Substances 0.000 abstract description 9
- 230000003213 activating effect Effects 0.000 abstract description 5
- 230000036772 blood pressure Effects 0.000 abstract description 5
- 230000001965 increasing effect Effects 0.000 abstract description 5
- 206010002660 Anoxia Diseases 0.000 abstract description 4
- 241000976983 Anoxia Species 0.000 abstract description 4
- 201000001320 Atherosclerosis Diseases 0.000 abstract description 4
- 206010011224 Cough Diseases 0.000 abstract description 4
- 206010021143 Hypoxia Diseases 0.000 abstract description 4
- 208000002193 Pain Diseases 0.000 abstract description 4
- 230000007953 anoxia Effects 0.000 abstract description 4
- 210000004204 blood vessel Anatomy 0.000 abstract description 4
- 235000012000 cholesterol Nutrition 0.000 abstract description 4
- 238000000034 method Methods 0.000 abstract description 4
- 230000008569 process Effects 0.000 abstract description 4
- 210000004351 coronary vessel Anatomy 0.000 abstract description 3
- 230000029087 digestion Effects 0.000 abstract description 3
- 238000010792 warming Methods 0.000 abstract description 3
- 206010036790 Productive cough Diseases 0.000 abstract description 2
- 208000024794 sputum Diseases 0.000 abstract description 2
- 210000003802 sputum Anatomy 0.000 abstract description 2
- 210000002784 stomach Anatomy 0.000 abstract description 2
- 241000209205 Coix Species 0.000 abstract 1
- 230000017531 blood circulation Effects 0.000 abstract 1
- 210000002381 plasma Anatomy 0.000 abstract 1
- 241000229143 Hippophae Species 0.000 description 16
- 235000021395 porridge Nutrition 0.000 description 16
- 210000000582 semen Anatomy 0.000 description 12
- 240000007594 Oryza sativa Species 0.000 description 6
- 235000007164 Oryza sativa Nutrition 0.000 description 6
- 208000007536 Thrombosis Diseases 0.000 description 6
- 241000271897 Viperidae Species 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- 238000011282 treatment Methods 0.000 description 6
- 235000009566 rice Nutrition 0.000 description 5
- 229940079593 drug Drugs 0.000 description 4
- 230000020764 fibrinolysis Effects 0.000 description 4
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 208000032843 Hemorrhage Diseases 0.000 description 3
- 235000003935 Hippophae Nutrition 0.000 description 3
- 241000243684 Lumbricus Species 0.000 description 3
- 230000032683 aging Effects 0.000 description 3
- 206010003549 asthenia Diseases 0.000 description 3
- 230000000740 bleeding effect Effects 0.000 description 3
- 108010052008 colla corii asini Proteins 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000035622 drinking Effects 0.000 description 3
- 230000002526 effect on cardiovascular system Effects 0.000 description 3
- 229940088598 enzyme Drugs 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 208000031971 Yin Deficiency Diseases 0.000 description 2
- 208000022531 anorexia Diseases 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 208000026106 cerebrovascular disease Diseases 0.000 description 2
- 206010061428 decreased appetite Diseases 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 206010016256 fatigue Diseases 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000001976 improved effect Effects 0.000 description 2
- 108010070324 lumbrokinase Proteins 0.000 description 2
- 208000030159 metabolic disease Diseases 0.000 description 2
- 230000004089 microcirculation Effects 0.000 description 2
- 229940012957 plasmin Drugs 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 230000035882 stress Effects 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 235000019640 taste Nutrition 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- HVCOBJNICQPDBP-UHFFFAOYSA-N 3-[3-[3,5-dihydroxy-6-methyl-4-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-2-yl]oxydecanoyloxy]decanoic acid;hydrate Chemical compound O.OC1C(OC(CC(=O)OC(CCCCCCC)CC(O)=O)CCCCCCC)OC(C)C(O)C1OC1C(O)C(O)C(O)C(C)O1 HVCOBJNICQPDBP-UHFFFAOYSA-N 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 102000007592 Apolipoproteins Human genes 0.000 description 1
- 108010071619 Apolipoproteins Proteins 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- 208000005623 Carcinogenesis Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 102000029816 Collagenase Human genes 0.000 description 1
- 108060005980 Collagenase Proteins 0.000 description 1
- 206010069729 Collateral circulation Diseases 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 241000190633 Cordyceps Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- 241000283087 Equus Species 0.000 description 1
- 241000283074 Equus asinus Species 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- 108010088842 Fibrinolysin Proteins 0.000 description 1
- 229930186217 Glycolipid Natural products 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 206010020564 Hyperadrenocorticism Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 102000004895 Lipoproteins Human genes 0.000 description 1
- 108090001030 Lipoproteins Proteins 0.000 description 1
- 206010024642 Listless Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 244000113306 Monascus purpureus Species 0.000 description 1
- 235000002322 Monascus purpureus Nutrition 0.000 description 1
- 206010028665 Myxoedema Diseases 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 235000007189 Oryza longistaminata Nutrition 0.000 description 1
- 240000002582 Oryza sativa Indica Group Species 0.000 description 1
- 240000008467 Oryza sativa Japonica Group Species 0.000 description 1
- 206010033645 Pancreatitis Diseases 0.000 description 1
- 102000013566 Plasminogen Human genes 0.000 description 1
- 108010051456 Plasminogen Proteins 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 108091006088 activator proteins Proteins 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 230000010100 anticoagulation Effects 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 238000004061 bleaching Methods 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 210000005013 brain tissue Anatomy 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000036952 cancer formation Effects 0.000 description 1
- 231100000504 carcinogenesis Toxicity 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 229960002424 collagenase Drugs 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 210000003792 cranial nerve Anatomy 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 208000017574 dry cough Diseases 0.000 description 1
- 230000002996 emotional effect Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 201000005577 familial hyperlipidemia Diseases 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 239000003527 fibrinolytic agent Substances 0.000 description 1
- 230000003480 fibrinolytic effect Effects 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 210000001156 gastric mucosa Anatomy 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 235000020710 ginseng extract Nutrition 0.000 description 1
- 229940089161 ginsenoside Drugs 0.000 description 1
- 229930182494 ginsenoside Natural products 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 210000005003 heart tissue Anatomy 0.000 description 1
- 230000011132 hemopoiesis Effects 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 208000003532 hypothyroidism Diseases 0.000 description 1
- 230000002989 hypothyroidism Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 description 1
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 1
- 235000008696 isoflavones Nutrition 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 208000017971 listlessness Diseases 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 229940057059 monascus purpureus Drugs 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 208000003786 myxedema Diseases 0.000 description 1
- 230000001338 necrotic effect Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 230000037081 physical activity Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 230000003234 polygenic effect Effects 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 235000019633 pungent taste Nutrition 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 102000005962 receptors Human genes 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 230000002537 thrombolytic effect Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 210000003556 vascular endothelial cell Anatomy 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 229940126673 western medicines Drugs 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L31/00—Edible extracts or preparations of fungi; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/10—Cereal-derived products
- A23L7/104—Fermentation of farinaceous cereal or cereal material; Addition of enzymes or microorganisms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/58—Reptiles
- A61K35/583—Snakes; Lizards, e.g. chameleons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
- A61K36/066—Clavicipitaceae
- A61K36/068—Cordyceps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/285—Aucklandia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8969—Polygonatum (Solomon's seal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
- A61K36/8994—Coix (Job's tears)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12G—WINE; PREPARATION THEREOF; ALCOHOLIC BEVERAGES; PREPARATION OF ALCOHOLIC BEVERAGES NOT PROVIDED FOR IN SUBCLASSES C12C OR C12H
- C12G3/00—Preparation of other alcoholic beverages
- C12G3/04—Preparation of other alcoholic beverages by mixing, e.g. for preparation of liqueurs
- C12G3/05—Preparation of other alcoholic beverages by mixing, e.g. for preparation of liqueurs with health-improving ingredients, e.g. flavonoids, flavones, polyphenols or polysaccharides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12G—WINE; PREPARATION THEREOF; ALCOHOLIC BEVERAGES; PREPARATION OF ALCOHOLIC BEVERAGES NOT PROVIDED FOR IN SUBCLASSES C12C OR C12H
- C12G3/00—Preparation of other alcoholic beverages
- C12G3/04—Preparation of other alcoholic beverages by mixing, e.g. for preparation of liqueurs
- C12G3/05—Preparation of other alcoholic beverages by mixing, e.g. for preparation of liqueurs with health-improving ingredients, e.g. flavonoids, flavones, polyphenols or polysaccharides
- C12G3/055—Preparation of other alcoholic beverages by mixing, e.g. for preparation of liqueurs with health-improving ingredients, e.g. flavonoids, flavones, polyphenols or polysaccharides extracted from plants
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/19—Preparation or pretreatment of starting material involving fermentation using yeast, bacteria or both; enzymatic treatment
Abstract
本发明公开了一种适用于高脂血症康复、散结化瘀、气血双调的食疗产品,所述食疗产品包括以下成分:沙棘、阿胶、肉桂、地龙蛋白、纳豆粉、红曲米、黄精、雪莲培养物、佛手、人参、蛹虫草、薏苡仁,将中药成分中的佛手、肉桂、黄精、人参、薏苡等加入到食用过程中,结合沙棘的食用时具有止咳化痰、健胃消食、活血散瘀的功效,以及肉桂散寒止痛,温通经脉,黄精和人参降血压、血糖的功效,增加心脏冠脉流量,提高耐缺氧能力,降减血浆胆固醇、减少血管壁中胆固醇含量的作用,能防治高血脂症和动脉粥样硬化症,除此之外,食料产品中还添加有地龙蛋白,食用过程中将所述成分熬粥或制备饮用酒,散结化瘀、气血双调,有利于高脂血症的康复和调节。
Description
技术领域
本发明属于食疗产品技术领域,具体涉及一种适用于高脂血症康复、散结化瘀、气血双调的食疗产品。
背景技术
高脂血症是指血脂水平过高,可直接引起一些严重危害人体健康的疾病,如动脉粥样硬化、冠心病、胰腺炎等。高脂血症可分为原发性和继发性两类。原发性与先天性和遗传有关,是由于单基因缺陷或多基因缺陷,使参与脂蛋白转运和代谢的受体、酶或载脂蛋白异常所致,或由于环境因素(饮食、营养、药物)和通过未知的机制而致。继发性多发生于代谢性紊乱疾病(糖尿病、高血压、黏液性水肿、甲状腺功能低下、肥胖、肝肾疾病、肾上腺皮质功能亢进),或与其他因素年龄、性别、季节、饮酒、吸烟、饮食、体力活动、精神紧张、情绪活动等有关。
而大部分治疗高脂血症都是使用药物治疗,药物治疗中西药治疗速度快,如果饮食不当,高血脂症还会重复出现;中药治疗一般都是用现有的中药材进行熬制,定时服用,治疗过程费时费力,因此需要研制一种食疗产品,可以在进食时,加入中药成分的食材,方便治疗,省时省力。
发明内容
为了克服现有技术的缺陷,利用现有的食品材料,提供一种适用于高脂血症康复、散结化瘀、气血双调的食疗产品。
本发明提供了一种适用于高脂血症康复、散结化瘀、气血双调的食疗产品,包括以下成分:沙棘、阿胶、肉桂、地龙蛋白、纳豆粉、红曲米、黄精,雪莲培养物、佛手、人参,蛹虫草、薏苡仁、蝮蛇、y-氨基丁酸、米糠脂肪烷醇。
进一步的,所述沙棘2-15份、阿胶1-5份、肉桂0-10份、地龙蛋白20-55 份、纳豆粉1-15份、红曲米10-20份、黄精15-25份,雪莲培养物0-2份、佛手 4-20份、人参13-23份、蛹虫草1-2份、薏苡仁4-27份。
进一步的,所述沙棘4份、阿胶2份、肉桂6份,地龙蛋白23份、纳豆粉 5份、红曲米12份、黄精16份、雪莲培养物2份、佛手4份、人参16份、蛹虫草1.5份、薏苡仁4份。
进一步的,所述食疗产品还包括蝮蛇、y-氨基丁酸、米糠脂肪烷醇的一种或几种。
与现有技术相比,本发明的优点和技术效果是:将中药成分中的佛手、肉桂、黄精、人参、薏苡等加入到食用过程中,结合沙棘的食用时具有止咳化痰、健胃消食、活血散瘀的功效,以及肉桂散寒止痛,温通经脉,黄精和人参降血压、血糖的功效,增加心脏冠脉流量,提高耐缺氧能力,降减血浆胆固醇、减少血管壁中胆固醇含量的作用,能防治高血脂症和动脉粥样硬化症,除此之外,食料产品中还添加有地龙蛋白,地龙蛋白具有改善微循环、溶解血栓、软化血管、降低血粘、双向调节血压、降低血糖的作用,食用过程中将所述成分熬粥或制备饮用酒,均具有散结化瘀、气血双调的作用,有利于高脂血症的康复和调节。
具体实施方式
下面结合具体实施方式对本发明技术方案作进一步详细的说明。
实施例1
取沙棘4份、阿胶2份、肉桂6份,地龙蛋白23份、纳豆粉8.5份、红曲米12份、黄精16份、雪莲培养物2份、佛手4份、人参16份、蛹虫草1.5份、薏苡仁4份熬制成粥,进行食用,或者放置在含有蝮蛇的储酒罐中等待食用。
实施例2
取沙棘6份、阿胶1份、肉桂8份,地龙蛋白22份、纳豆粉7份、红曲米11份、黄精15份、雪莲培养物1份、佛手7份、人参13份、蛹虫草2份、薏苡仁7份熬制成粥,进行食用,或者放置在含有蝮蛇的储酒罐中等待食用。
实施例3
取沙棘2份、阿胶5份、肉桂7份,地龙蛋白23份、纳豆粉5份、红曲米12份、黄精16份、雪莲培养物2份、佛手4份、人参16份、蛹虫草1.5 份、薏苡仁6.5份熬制成粥,进行食用,或者放置在含有蝮蛇的储酒罐中等待食用。
实施例4
取沙棘15份、阿胶2份、肉桂7份,地龙蛋白20份、纳豆粉5份、红曲米12份、黄精15份、雪莲培养物0份、佛手4份、人参13份、蛹虫草1.5 份、薏苡仁5.5份熬制成粥,进行食用,或者放置在含有蝮蛇的储酒罐中等待食用。
实施例5
取沙棘2份、阿胶1份、肉桂9份,地龙蛋白30份、纳豆粉1份、红曲米10份、黄精16份、雪莲培养物0份、佛手4份、人参13份、蛹虫草1份、薏苡仁13份熬制成粥,进行食用,或者放置在含有蝮蛇的储酒罐中等待食用。
实施例6
取沙棘4份、阿胶2份、肉桂0份,地龙蛋白23份、纳豆粉15份、红曲米12份、黄精15份、雪莲培养物1份、佛手4份、人参13份、蛹虫草1份、薏苡仁14份熬制成粥,进行食用,或者放置在含有蝮蛇的储酒罐中等待食用。
实施例7
取沙棘7份、阿胶3份、肉桂0份,地龙蛋白23份、纳豆粉5份、红曲米10份、黄精25份、雪莲培养物2份、佛手4份、人参13份、蛹虫草2份、薏苡仁6份熬制成粥,进行食用,或者放置在含有蝮蛇的储酒罐中等待食用。
实施例8
取沙棘3份、阿胶3份、肉桂7份,地龙蛋白20份、纳豆粉1份、红曲米20份、黄精17份、雪莲培养物1份、佛手4份、人参17份、蛹虫草1份、薏苡仁6份熬制成粥,进行食用,或者放置在含有蝮蛇的储酒罐中等待食用。
在上述实施例中,实施例1中长期煮粥食用最佳,实施例5中在储酒罐中食用最佳;以下为关于本发明成分及原理功效的表述:
沙棘:性温,味甘、酸、涩,归脾、胃、肺、心经,具有健脾消食、止咳祛痰、活血散瘀的功效,并且沙棘油中含有206种对人体有益的活性物质,其中有46种生物活性物质,含有大量的维生素E、维生素A、黄酮等,具有抗疲劳和增强机体活力及抗癌等特殊药理性能,具有保护和加速修复胃黏膜、增加肠道双歧杆菌的药性,有降减血浆胆固醇、减少血管壁中胆固醇含量的作用,能防治高血脂症和动脉粥样硬化症,并有促进伤口愈合的作用。
阿胶:为马科驴属动物驴Equus asinus L.的皮,经漂泡去毛后熬制而成的胶块。具有补血,滋阴,润肺,止血的功效。主治血虚诸证,出血证,肺阴虚燥咳,热病伤阴,心烦失眠,阴虚风动,手足瘈疭,具有补血,滋阴,润肺,止血的功能。
肉桂:为植物干燥的皮,味辛、甘,性大热,有有补火助阳,引火归元,散寒止痛,温通经脉的功效。
地龙蛋白:地龙蛋白中含有胶原酶、纤溶酶、蚓激酶、纤溶激活蛋白、核酸、微量元素等多种成分,其分子量在5000-10000,属于短链小分子物质,能顺畅的进入微血管,溶解微血管内的微栓,让硬化的微血管恢复弹性,从而解除微血管的堵塞、扭曲变形情况。
其中,纤溶酶和蚓激酶能直接溶解形成人体血栓的主体物质纤维蛋白,从而发挥强力的直接溶栓作用;纤溶激活蛋白则是激活人体中的tPA,再由自身产生纤溶酶原,进而转化为人体的纤溶酶,由于这种方式是由人自己产生纤溶酶,这样间接溶解血栓,就大幅提高了其安全性。
它能溶解新鲜及陈旧性血栓,提高人体自身的抗凝功能,能激活血管内皮细胞的分化特性,打通经脉、促进微血管再生,建立侧枝循环,为病灶区的心脑组织开辟新的血液通路,修复坏死的脑神经细胞,治愈偏瘫,从而达到持续溶栓的效果,对心脑血管病的预防,中风后遗症的康复意义重大。同时又有助于消除与微循环障碍有关的衰老和肿瘤发生,改善全身多种生理机能和健康状况,提高免疫力。
纳豆粉:纳豆粉主要是用纳豆为主要原材料制作而成的一种营养食品,其中含有非常丰富的异黄酮和不饱和脂肪酸。除此之外,卵磷脂、叶酸、纤维素、钙离子等成分也比较丰富,摄入体内之后可以促进新陈代谢,加速肠道内废物的排除,可以改善便秘,并且可以调节血糖,能够在一定程度上溶解血栓,可以预防心脑血管疾病。
红曲米:以籼稻、粳稻、糯米等稻米为原料,用红曲霉菌发酵而成,为棕红色或紫红色米粒。
黄精:味甘,性平;补中益气,润心肺,强筋骨作用;主治虚损寒热,肺痨咳血,病后体虚食少,筋骨软弱,风湿疼痛,风癞癣疾等;现代中药药理研究显示黄精具有降血糖,降脂抗动脉硬化,降低血压,增加心脏冠脉流量,提高耐缺氧能力,降低心肌脂褐素和提高肝脏SOD活性,抗氧化抗自由基显著,故能增强体质抗衰老,改善糖脂代谢紊乱,提高免疫力。
人参:味甘、味苦,性温;大补元气,生津止渴,安神益智;主治劳伤虚损,食少倦怠,反胃吐食,眩晕头痛,阳痿,尿频,消渴,妇女崩漏,小儿惊悸,久虚不复等一切气血津液不足之证;现代药理研究显示,具有明显降低血糖,保护肝脏,促进肝细胞再生恢复肝功能,提高肝脏解毒功能,抗衰老,促进学习和记忆力,抗肿瘤,提高免疫力,抗氧化,抗应激,抗辐射,强心,扩张心血管,抗心肌缺血,抗缺氧、保护心肌,降低血粘度,保护和刺激骨髓造血功能,人参皂甙促进刺激垂体-肾上腺皮质功能,促进蛋白质合成,抗溃疡,促性激素样作用(雌性为主),本发明产品所用的人参为人工种植的人参。
以上为对本发明占本产品中组分比较重要的配比组分,其余组分中的雪莲培养物、佛手、蛹虫草、薏苡仁在食用过程中都发挥各自的中药应有的功效,增加体内y-氨基丁酸、米糠脂肪烷醇的含量,y-氨基丁酸具有镇定神经、抗焦虑、减少血压、医治疾患、减少血氨、提升脑魅力、推动酒精新陈代谢等功效,从而达到散结化瘀、气血双调的作用。并且以上所述的实施例,仅是本发明的实施例而已,并非对本发明作任何形式上的限制,任何熟悉本领域的技术人员,在不脱离本发明技术方案范围情况下,利用上述揭示的方法内容对本发明技术方案做出许多可能的变动和修饰,均属于权利要求书保护的范围。
Claims (4)
1.一种适用于高脂血症康复、散结化瘀、气血双调的食疗产品,其特征在于:所述食疗产品包括以下成分:沙棘、阿胶、肉桂、地龙蛋白、纳豆粉、红曲米、黄精、雪莲培养物、佛手、人参、蛹虫草、薏苡仁。
2.根据权利要求1所述的一种适用于高脂血症康复、散结化瘀、气血双调的食疗产品,其特征在于:所述沙棘2-15份、阿胶1-5份、肉桂0-10份、地龙蛋白20-55份、纳豆粉1-15份、红曲米10-20份、黄精15-25份,雪莲培养物0-2份、佛手4-20份、人参13-23份、蛹虫草1-2份、薏苡仁4-27份。
3.根据权利要求2所述的一种适用于高脂血症康复、散结化瘀、气血双调的食疗产品,其特征在于:所述沙棘4份、阿胶2份、肉桂6份,地龙蛋白23份、纳豆粉8.5份、红曲米12份、黄精16份、雪莲培养物2份、佛手4份、人参16份、蛹虫草1.5份、薏苡仁4份。
4.根据权利要求3所述的一种适用于高脂血症康复、散结化瘀、气血双调的食疗产品,其特征在于:所述食疗产品通过熬制或者放置在含有蝮蛇的储酒罐中制作而成。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110384415.3A CN113080447A (zh) | 2021-04-09 | 2021-04-09 | 一种适用于高脂血症康复、散结化瘀、气血双调的食疗产品 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110384415.3A CN113080447A (zh) | 2021-04-09 | 2021-04-09 | 一种适用于高脂血症康复、散结化瘀、气血双调的食疗产品 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN113080447A true CN113080447A (zh) | 2021-07-09 |
Family
ID=76676042
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110384415.3A Pending CN113080447A (zh) | 2021-04-09 | 2021-04-09 | 一种适用于高脂血症康复、散结化瘀、气血双调的食疗产品 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113080447A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115105572A (zh) * | 2022-05-27 | 2022-09-27 | 山东圣鳖生物科技发展有限公司 | 一种可抑制肿瘤调理心脑血管增加细胞分裂修复组织配方 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103622002A (zh) * | 2012-08-29 | 2014-03-12 | 浙江劲膳美生物科技有限公司 | 改善贫血食疗配餐或代餐品 |
CN103621990A (zh) * | 2012-08-28 | 2014-03-12 | 浙江劲膳美生物科技有限公司 | 一种阳虚体质食疗配餐或代餐品 |
CN104587441A (zh) * | 2015-02-11 | 2015-05-06 | 代川山 | 一种调节心脑血管疾病的中药组合物及其制备方法 |
CN104940606A (zh) * | 2015-06-09 | 2015-09-30 | 贵州广济堂药业有限公司 | 调理八种偏颇体质的鹿胶保健品 |
-
2021
- 2021-04-09 CN CN202110384415.3A patent/CN113080447A/zh active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103621990A (zh) * | 2012-08-28 | 2014-03-12 | 浙江劲膳美生物科技有限公司 | 一种阳虚体质食疗配餐或代餐品 |
CN103622002A (zh) * | 2012-08-29 | 2014-03-12 | 浙江劲膳美生物科技有限公司 | 改善贫血食疗配餐或代餐品 |
CN104587441A (zh) * | 2015-02-11 | 2015-05-06 | 代川山 | 一种调节心脑血管疾病的中药组合物及其制备方法 |
CN104940606A (zh) * | 2015-06-09 | 2015-09-30 | 贵州广济堂药业有限公司 | 调理八种偏颇体质的鹿胶保健品 |
Non-Patent Citations (1)
Title |
---|
王佳: "保健食品产品-原料-原料文献数据库", 《中国优秀硕士学位论文全文数据库工程科技I辑》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115105572A (zh) * | 2022-05-27 | 2022-09-27 | 山东圣鳖生物科技发展有限公司 | 一种可抑制肿瘤调理心脑血管增加细胞分裂修复组织配方 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105995720A (zh) | 一种酵素莱阳梨膏及其制备方法和应用 | |
CN103263608A (zh) | 一种排毒养颜的中药原粉 | |
CN102511867B (zh) | 红枣阿胶枸杞浓浆及其生产工艺 | |
CN105412623A (zh) | 治疗脂肪肝、前列腺炎、肾痛肾炎、高血压及糖尿病的药物 | |
CN104740439A (zh) | 降糖降脂减肥恢复胰岛功能防治糖尿病并发症的药膳粉 | |
CN106937741A (zh) | 一种脱脂亚麻籽粉防癌抗癌健康减肥法及其制备方法 | |
CN1698875A (zh) | 一种治疗癌症的药酒 | |
CN113080447A (zh) | 一种适用于高脂血症康复、散结化瘀、气血双调的食疗产品 | |
CN100574786C (zh) | 一种甲鱼制剂的生产工艺 | |
CN111249393A (zh) | 一种补血抗衰的鹿胎盘营养素软胶囊及其制作方法 | |
CN106176909A (zh) | 一种用人参白术茯苓甘草制备四君子酵素饮料的方法 | |
CN105852061A (zh) | 一种百香果酵素及其制备方法 | |
CN109730222A (zh) | 酵素复合液及其保健饮料 | |
CN104388263A (zh) | 山楂桂圆养生中药酒及制备方法 | |
CN111418803A (zh) | 一种养生汤的配制方法 | |
CN102783651B (zh) | 一种营养与活化细胞的五行宝 | |
CN104726301A (zh) | 舒缓疲劳养生酒 | |
CN1063963C (zh) | 防治中风的枫荷桂药酒配制方法 | |
CN108355054A (zh) | 一种养生药酒 | |
CN101829225A (zh) | 一种疏通微循环的保健品及其制备方法 | |
CN111407868B (zh) | 改善大脑认知功能的中药丸剂 | |
KR101954339B1 (ko) | 유황오리 엑기스의 제조방법 | |
CN105395850A (zh) | 补血兼补气的药物及保健品 | |
CN114010755A (zh) | 一种控制尿酸的制剂及其配制方法 | |
CN116509940A (zh) | 一种芪柏养心口服液的制备方法及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210709 |
|
RJ01 | Rejection of invention patent application after publication |